American Trust’s Labcorp LH Stock Holding History

American Trust’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-782	Closed	-$211K	–	521
2021 Q4	$211K	Buy	+782	New	+$194K	0.02%	341

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Trust's LH Position: Q1 2022 in Review

American Trust sold out of Labcorp (LH) in Q1 2022, closing a stake of 782 shares — an estimated $211K sold.

American Trust first reported a position in LH in Q4 2021 and held it in 1 quarter. The position peaked at $211K in Q4 2021. 1,033 funds tracked by Wall St. Rank hold LH as of Q1 2022.

American Trust reported no remaining Labcorp position as of Q1 2022 after selling out during the quarter.
American Trust sold 782 Labcorp shares in Q1 2022, an estimated $211K.
American Trust first reported a position in Labcorp in Q4 2021 and held it in 1 quarter.
American Trust's Labcorp position peaked at $211K in Q4 2021.
1,033 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on American Trust's 13F filing for Q1 2022, filed 8 Jun 2022.